<bill session="116" type="h" number="4712" updated="2020-12-28T14:37:13Z">
  <state datetime="2020-11-17T12:36:54-05:00">PASS_OVER:HOUSE</state>
  <status>
    <unknown datetime="2020-11-17T12:36:54-05:00"/>
  </status>
  <introduced datetime="2019-10-17"/>
  <titles>
    <title type="short" as="introduced">Fairness in Orphan Drug Exclusivity Act</title>
    <title type="short" as="reported to house">Fairness in Orphan Drug Exclusivity Act</title>
    <title type="short" as="passed house">Fairness in Orphan Drug Exclusivity Act</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act with respect to limitations on exclusive approval or licensure of orphan drugs, and for other purposes.</title>
    <title type="display">Fairness in Orphan Drug Exclusivity Act</title>
  </titles>
  <sponsor bioguide_id="D000631"/>
  <cosponsors>
    <cosponsor bioguide_id="C001103" joined="2019-10-17"/>
    <cosponsor bioguide_id="K000394" joined="2020-07-16"/>
    <cosponsor bioguide_id="M001180" joined="2019-10-17"/>
    <cosponsor bioguide_id="S001200" joined="2020-08-04"/>
    <cosponsor bioguide_id="T000479" joined="2020-11-16"/>
    <cosponsor bioguide_id="T000469" joined="2019-12-05"/>
    <cosponsor bioguide_id="V000131" joined="2019-10-17"/>
  </cosponsors>
  <actions>
    <action datetime="2019-10-17">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-10-17" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2019-10-18">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2020-03-11">
      <text>Subcommittee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2020-03-11">
      <text>Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .</text>
    </action>
    <action datetime="2020-07-15">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <calendar datetime="2020-07-15" state="REPORTED">
      <text>Ordered to be Reported (Amended) by Voice Vote.</text>
    </calendar>
    <action datetime="2020-11-16">
      <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-572.</text>
    </action>
    <calendar datetime="2020-11-16" calendar="Union" number="470">
      <text>Placed on the Union Calendar, Calendar No. 470.</text>
    </calendar>
    <action datetime="2020-11-17T12:25:15-05:00">
      <text>Mr. Pallone moved to suspend the rules and pass the bill, as amended.</text>
    </action>
    <action datetime="2020-11-17T12:25:42-05:00">
      <text>Considered under suspension of the rules.</text>
      <reference ref="CR H5807-5809" label="consideration"/>
    </action>
    <action datetime="2020-11-17T12:25:47-05:00">
      <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 4712.</text>
    </action>
    <vote how="by voice vote" type="vote" datetime="2020-11-17T12:36:54-05:00" where="h" result="pass" state="PASS_OVER:HOUSE">
      <text>On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.</text>
      <reference ref="CR H5807" label="text"/>
    </vote>
    <action datetime="2020-11-17T12:36:58-05:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <action datetime="2020-11-18">
      <text>Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Reporting, Markup, Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Reporting, Markup, Referral"/>
  </committees>
  <relatedbills>
    <bill type="s" session="116" relation="unknown" number="3271"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Competition and antitrust"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Licensing and registrations"/>
    <term name="Marketing and advertising"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <committee-reports>
    <report>H. Rept. 116-572</report>
  </committee-reports>
</bill>
